U.S. approves Barr generic version of Roche's Vesanoid

(Reuters) - Barr said it plans to launch 10 mg capsules of tretinoin immediately. Vesanoid had sales of $24 million in the year to April, the company said.



Roche Laboratories is a subsidiary of Swiss drug maker Roche Holdings AG


Read more at Reuters.com Government Filings News